Broadcast

The Science of Radiofrequency Renal Denervation

Stefan Tunev, Andrew SP Sharp

Watch time: 1h 12m 55s

Broadcast

Nocturnal Hypertension

Roland Asmar, , , et al

Watch time: 1h 9m 26s

About

Hypertension is the most common modifiable risk factor for cardiovascular disease and death, and lowering blood pressure with antihypertensive drugs reduces target organ damage and prevents cardiovascular disease outcomes.

Most hypertensive patients will need a combination of antihypertensive agents to achieve the therapeutic goals. Recent guidelines recommend initiating treatment with two drugs in those patients with a systolic blood pressure >20 mmHg and/or a diastolic blood pressure >10 mmHg above the goals, and in those patients with high cardiovascular risk. In addition, approximately 25% of patients will require three antihypertensive agents to achieve the therapeutic targets.

Articles

The Impact of Angiotensin-II Receptor Blockers on Cardiovascular Events in Hypertensive Patients - Evidence from Real-life Databases

Citation:

European Cardiology 2010;6(3):33–8

Blood Pressure Lowering for the Prevention of Stroke Recurrence

Citation:

European Cardiology 2010;6(1):37–40

Atrial Fibrillation and Renin-Angiotensin System Blockade in Hypertension

Citation:

European Cardiology 2009;5(2):63–8

Adjusting Therapy in Pulmonary Arterial Hypertension - The Role of Novel Echocardiographic Techniques

Citation:

European Cardiology 2010;6(4):26–30